Antimuscarinic anticholinergic medications in Parkinson disease: To prescribe or deprescribe?

2021 ◽  
Author(s):  
Matthew J. Barrett ◽  
Lana Sargent ◽  
Huma Nawaz ◽  
Daniel Weintraub ◽  
Elvin T. Price ◽  
...  
Keyword(s):  
Parkinson Disease ◽  
Anticholinergic Medications

Pharmacology Issues Related to Dementia Syndrome of Depression in Elderly Residents of Long-Term Care Settings

2015 ◽  
Vol 25 (2) ◽  
pp. 61-69
Author(s):  
Angel L. Ball ◽  
Adina S. Gray
Keyword(s):  
Depressive Symptoms ◽  
The Elderly ◽  
Environmental Communication ◽  
Pharmacological Intervention ◽  
Team Approach ◽  
Discussion Paper ◽  
Term Care ◽  
Anticholinergic Medications ◽  
Inappropriate Treatment ◽  
Dementia Syndrome

Pharmacological intervention for depressive symptoms in institutionalized elderly is higher than the population average. Among the patients on such medications are those with a puzzling mix of symptoms, diagnosed as “dementia syndrome of depression,” formerly termed “pseudodementia”. Cognitive-communicative changes, potentially due to medications, complicate the diagnosis even further. This discussion paper reviews the history of the terminology of “pseudodementia,” and examines the pharmacology given as treatment for depressive symptoms in the elderly population that can affect cognition and communication. Clinicians can reduce the risk of misdiagnosis or inappropriate treatment by having an awareness of potential side effects, including decreased attention, memory, and reasoning capacities, particularly due to some anticholinergic medications. A team approach to care should include a cohesive effort directed at caution against over-medication, informed management of polypharmacology, enhancement of environmental/communication supports and quality of life, and recognizing the typical nature of some depressive signs in elderly institutionalized individuals.

Neurologist care in Parkinson disease: A utilization, outcomes, and survival study

2012 ◽  
Vol 2012 ◽  
pp. 61-62
Author(s):  
B. Robottom
Keyword(s):  
Parkinson Disease ◽  
Survival Study

Therapies for Dopaminergic-Induced Dyskinesias in Parkinson Disease

2012 ◽  
Vol 2012 ◽  
pp. 66-67
Author(s):  
B. Robottom
Keyword(s):  
Parkinson Disease

Neuropathy in Parkinson disease: Prevalence and determinants

2012 ◽  
Vol 2012 ◽  
pp. 116-117
Author(s):  
C.G. Mazia
Keyword(s):  
Parkinson Disease ◽  
Disease Prevalence

Altered DAT function in a mouse model of Parkinson disease

2011 ◽  
Author(s):  
D. Leo ◽  
M. J. Bourque ◽  
C. Kortleven ◽  
E. A. Fon ◽  
L. E. Trudeau
Keyword(s):  
Mouse Model ◽  
Parkinson Disease

Parkinson disease setback

2020 ◽  
Vol 19 (6) ◽  
pp. 373-373
Author(s):  
Asher Mullard
Keyword(s):  
Parkinson Disease
Sign in / Sign up

Export Citation Format

Share Document